These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15302960)

  • 21. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
    Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
    Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
    Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
    Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
    Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and purification of the complete PreS region of hepatitis B Virus.
    Deng Q; Kong YY; Xie YH; Wang Y
    World J Gastroenterol; 2005 May; 11(20):3060-4. PubMed ID: 15918190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.
    Michel ML; Davis HL; Schleef M; Mancini M; Tiollais P; Whalen RG
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5307-11. PubMed ID: 7777503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
    Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
    Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
    Chen X; Li M; Le X; Ma W; Zhou B
    Vaccine; 2004 Jan; 22(3-4):439-46. PubMed ID: 14670326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine.
    Beaumont E; Roingeard P
    Vaccine; 2015 Feb; 33(8):973-6. PubMed ID: 25596457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice.
    Cai X; Zheng W; Pan S; Zhang S; Xie Y; Guo H; Wang G; Li Z; Luo M
    Antiviral Res; 2018 Jan; 149():48-57. PubMed ID: 29129705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High level expression of hepatitis B virus preS1 peptide in Escherichia coli.
    Rhyum SB; Jin BR; Park HR; Hong HJ
    J Biotechnol; 1994 Aug; 36(3):221-30. PubMed ID: 7765264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression and purification of PreS region of hepatitis B virus antigenic surface protein adr subtype in Escherichia coli.
    Abbas N; Ahmad A; Shakoori AR
    J Biochem Mol Biol; 2007 Nov; 40(6):1002-8. PubMed ID: 18047797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.
    Ferrari C; Penna A; Bertoletti A; Cavalli A; Valli A; Schianchi C; Fiaccadori F
    J Clin Invest; 1989 Oct; 84(4):1314-9. PubMed ID: 2529268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F; Peterson D; Hughes J; Milich DR
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay.
    Wei J; Wang YQ; Lu ZM; Li GD; Wang Y; Zhang ZC
    World J Gastroenterol; 2002 Apr; 8(2):276-81. PubMed ID: 11925607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of a recombinant yeast-derived hepatitis B surface antigen containing S, preS2 and preS1 antigenic domains.
    Petre J; Rutgers T; Hauser P
    Arch Virol Suppl; 1992; 4():137-41. PubMed ID: 1280502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Dobrica MO; Lazar C; Paruch L; van Eerde A; Clarke JL; Tucureanu C; Caras I; Ciulean S; Onu A; Tofan V; Branzan A; Urban S; Stavaru C; Branza-Nichita N
    Vaccine; 2018 Sep; 36(38):5789-5795. PubMed ID: 30082163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children.
    Gerner PR; Friedt M; Oettinger R; Lausch E; Wirth S
    Virology; 1998 May; 245(1):163-72. PubMed ID: 9614877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.